中财网 中财网股票行情
迪哲医药-U(688192)财务分析指标    年份：
截止日期2026-03-312025-12-312025-09-302025-06-302025-03-31
营业总收入(万元)25252.1980113.5658630.1135500.1415964.15
营业收入(万元)25252.1980113.5658630.1135500.1415964.15
营业总成本(万元)36528.73165417.85123549.0177960.7138202.15
营业成本(万元)1029.053422.892532.521562.74707.16
净利润(万元)-9555.74-76404.95-57994.78-37736.01-19251.33
归属于母公司的净利润(万元)-9555.74-76404.95-57994.78-37736.01-19251.33
营业利润(万元)-9636.64-76636.27-58290.11-37899.03-19374.07
利润总额(万元)-9634.23-76712.67-58290.11-37899.03-19374.07
少数股东损益(万元)-114.48-446.80-300.54-168.23-122.74
基本每股收益(元)-0.21(元)-1.71(元)-1.32(元)-0.87(元)-0.46(元)
稀释每股收益(元)-0.21(元)-1.71(元)-1.32(元)-0.87(元)-0.46(元)
非经常性损益(万元)1327.52--5071.31----
扣除非经常性损益后净利润(万元)-10883.26-84155.30-63066.09-41923.13-21948.52
总资产(万元)301301.97300252.92295534.66321846.06180483.95
总负债(万元)177783.89170683.83151161.32158968.31178130.54
归属于母公司股东权益合计(万元)123449.25129385.77144043.77162415.871846.04
股东权益合计(万元)123518.08129569.08144373.34162877.752353.41
实收资本(股本)(万元)46463.3346118.7945941.2945941.2941764.81
资本公积(万元)498898.72495624.05492049.38490162.71315284.68
未分配利润(万元)-421912.80-412357.06-393946.89-373688.13-355203.45
经营活动产生的现金流量净额(万元)-20047.76-58832.48-42405.68-26466.94-13166.70
经营活动现金流入小计(万元)26906.6284612.7459511.6738202.2218948.05
经营活动现金流出小计(万元)46954.38143445.22101917.3664669.1632114.75
投资活动产生的现金流量净额(万元)-9343.45-119870.88-45203.33-51722.78-12865.01
投资活动现金流入小计(万元)189647.90996876.02728291.00363160.4673218.27
投资活动现金流出小计(万元)198991.351116746.90773494.33414883.2486083.28
筹资活动产生的现金流量净额(万元)22634.62182868.49164090.84177637.5726261.71
筹资活动现金流入小计(万元)42530.81260414.35233358.57233358.5739134.35
筹资活动现金流出小计(万元)19896.1977545.8669267.7355721.0112872.64
期末现金及现金等价物余额(万元)22342.2129114.66101448.46124429.0925223.16
最后修改日期2026-04-302026-03-302025-11-012025-08-222025-04-29
↑返回页顶↑

转至迪哲医药-U（688192）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。